Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer.
- Citation:
- Int J Radiat Oncol Biol Phys vol 65 (4) 1106-11
- Year:
- 2006
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- http://www.sciencedirect.com/science/article/pii/S0360301606003762
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- CA-15083, CA-25224, CA-35101, CA-35103, CA-35415, CA-37404, CA-37417, CA-60276
- Corr. Author:
- Authors:
- Steven E Schild William L McGinnis David Graham Shauna Hillman Tom R Fitch Donald Northfelt Yolanda I Garces Homayoon Shahidi Loren K Tschetter Paul L Schaefer Alex Adjei James Jett
- Networks:
- Study
- NCCTG-N0028
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 1
- Keywords:
- Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Area Under Curve, Carboplatin, Carcinoma, Non-Small-Cell Lung, Combined Modality Therapy, Female, Humans, Lung Neoplasms, Male, Maximum Tolerated Dose, Middle Aged, Paclitaxel, Radiation Pneumonitis, Radiotherapy Dosage, Radiotherapy Planning, Computer-Assisted